Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Magnesium Hydride and Respiratory Distress in Lab Cell Studies

Magnesium Hydride Ameliorates Endotoxin-Induced Acute Respiratory Distress Syndrome by Inhibiting Inflammation, Oxidative Stress, and Cell Apoptosis

Research hubs: Respiratory System

This research was done on cells or tissue in a lab, not in people or animals.

Scientific visualization of hydrogen therapy research for Magnesium Hydride Ameliorates Endotoxin-Induced Acute Respiratory Distress Syndrome by Inhibiting Inflammation, Oxidative Stress, and Cell Apoptosis
Evidence type
Laboratory study (cells or tissue)
Authors
Xuan Shi, Lina Zhu, Sheng Wang, Wanli Zhu, Quanfu Li, Juan Wei, Di Feng, Meiyun Liu, Yuanli Chen, Xuejun Sun, Hongtao Lu, Xin Lv
Journal
Oxidative Medicine and Cellular Longevity
Year
2022
Study Type
Mouse
Delivery
Water (Mg-Chemico)
Outcome
Positive
Peer Reviewed
Yes
Cited by
24 (OpenAlex, as of November 2026)
Country
China

TL;DR

Magnesium hydride (MgH2) could potentially help treat a severe lung condition called ARDS by reducing inflammation, oxidative damage, cell death, and improving lung cell barriers.

Key Finding

Magnesium hydride reduced inflammation, oxidative stress, and cell death in laboratory and animal models of acute respiratory distress syndrome, with treated mice showing improved survival rates and less lung damage.

Summary

This study tested whether magnesium hydride (a compound that releases hydrogen) could protect against acute respiratory distress syndrome (ARDS), a serious lung condition involving severe inflammation. Using lab cells and mice, researchers found that magnesium hydride reduced inflammation, decreased harmful molecules called free radicals, prevented cell death, and strengthened the barrier that lines the lungs—all effects that improved survival in treated mice.

Practical Takeaway

While this early-stage research in cells and mice suggests hydrogen-releasing compounds may have protective effects in severe lung disease, these findings cannot yet be applied to humans. Much more research, including human clinical trials, would be needed before any therapeutic claims could be made about hydrogen water or magnesium hydride for respiratory health.

Abstract (excerpt)

Acute respiratory distress syndrome (ARDS) causes uncontrolled pulmonary inflammation, resulting in high morbidity and mortality in severe cases. Given the antioxidative effect of molecular hydrogen, some recent studies suggest the potential use of molecular hydrogen as a biomedicine…

Read the full abstract on PubMed